Browsing Tag
heart failure
26 posts
Can AI predict heart failure years earlier? Inside Anumana’s breakthrough AHA 2025 results
Anumana’s FDA-cleared ECG-AI platform enhances heart failure prediction and expands into perioperative care with Boston Scientific’s backing. Learn more.
AHA 2025 spotlight: sotagliflozin data spark debate on benefits in HFpEF patients without diabetes
Find out how sotagliflozin’s debated HFpEF results at AHA 2025 could change heart-failure therapy beyond diabetes.
FDA approves Ligand Partner SQ Innovation’s Lasix ONYU for heart failure edema—at-home use marks major shift in care
Find out how Ligand and SQ Innovation’s FDA-approved Lasix ONYU is redefining heart-failure treatment with the first at-home edema therapy.
Axon Therapies bags $32m to push heart failure trials—can this MedTech deliver where drugs failed?
Axon Therapies raises $32M to advance implant-free heart failure therapy. Learn how its splanchnic ablation trials could reshape cardiology.
Can real-time blood-volume monitoring finally cut heart failure readmissions?
Discover how FDA-cleared blood-volume monitoring devices like Daxor’s could help hospitals reduce costly heart failure readmissions.
Daxor wins FDA clearance for handheld blood-volume analyzer built with U.S. Department of Defense
Daxor secures FDA clearance for its rapid handheld blood-volume analyzer. Find out how this innovation could reshape heart failure and critical care.
Alkem Laboratories’ latest drug launch promises relief for millions of diabetics in India
Alkem Laboratories Limited has launched its generic version of empagliflozin and its combinations in India under the brand…
Aeson total artificial heart shows promise for heart failure patients with pulmonary hypertension
A significant advancement in pulmonary hypertension treatment for heart failure patients has emerged with the latest study on…
Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment
Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company…
Bayer announces start of Phase 2 GenePHIT trial for AB-1002
Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against…